Literature DB >> 34125237

[Neurolaryngology].

Andreas H Müller1.   

Abstract

Neurological and neurophysiological knowledge of neuromuscular diseases is combined in neurolaryngology with experience from laryngology. Laryngeal electromyography (LEMG) is the most important diagnostic and prognostic tool in neurolaryngology. It can be combined with diagnostic electrostimulation. Interest in LEMG today extends beyond the thyroarytenoid muscle to all accessible laryngeal muscles. LEMG should be performed and interpreted according to a standardized protocol. Main applications of LEMG are confirmation, topodiagnostic and prognostic assessment of vocal fold paralysis. It is possible to differentiate fresh from old recurrent laryngeal nerve lesions as well as mechanical vocal fold fixations from paralysis. Needle guidance for botulinum toxin injections in spasmodic dysphonia and for augmentation laryngoplasty can be supported by LEMG, but also by laryngeal ultrasound. The timing of therapy for temporary and permanent augmentations, thyroplasty and reinnervation surgery may be better defined with experience from neurolaryngology. The use of diagnostic neurostimulation can reveal any remaining active movement potential of a vocal fold and thus help identify candidates for future laryngeal pacemaker treatments. Other topics in neurolaryngology include spasmodic dysphonia and underlying neurological diseases such as stroke, central vocal fold paralysis, essential tremor and Parkinson's disease. Laryngoscopic, clinical and LEMG characteristics of these diseases are presented.

Entities:  

Keywords:  Dysphonia; Implantable neurostimulators; Larynx; Neurophysiology; Vocal fold paralysis

Year:  2021        PMID: 34125237     DOI: 10.1007/s00106-021-01064-7

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  1 in total

1.  Diagnostic laryngeal electromyography: The Wake Forest experience 1995-1999.

Authors:  J A Koufman; G N Postma; C S Whang; C J Rees; M R Amin; P C Belafsky; P E Johnson; K M Connolly; F O Walker
Journal:  Otolaryngol Head Neck Surg       Date:  2001-06       Impact factor: 3.497

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.